 Connection
Pedro Delgado to Depressive Disorder, Major
This is a "connection" page, showing publications Pedro Delgado has written about Depressive Disorder, Major.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.648 |
|
|
|
-
Moreno FA, Parkinson D, Palmer C, Castro WL, Misiaszek J, El Khoury A, Math? AA, Wright R, Delgado PL. CSF neurochemicals during tryptophan depletion in individuals with remitted depression and healthy controls. Eur Neuropsychopharmacol. 2010 Jan; 20(1):18-24.
Score: 0.251
-
Delgado PL, Brannan SK, Mallinckrodt CH, Tran PV, McNamara RK, Wang F, Watkin JG, Detke MJ. Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder. J Clin Psychiatry. 2005 Jun; 66(6):686-92.
Score: 0.183
-
Aronson S, Delgado P. Escitalopram. Drugs Today (Barc). 2004 Feb; 40(2):121-31.
Score: 0.167
-
Wohlreich MM, Mallinckrodt CH, Watkin JG, Wilson MG, Greist JH, Delgado PL, Fava M. Immediate switching of antidepressant therapy: results from a clinical trial of duloxetine. Ann Clin Psychiatry. 2005 Oct-Dec; 17(4):259-68.
Score: 0.047
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|